Inhibitory effects of prostaglandin A1 on membrane transport of folates mediated by both the reduced folate carrier and ATP-driven exporters

Biochemical Pharmacology

Volumn 58, Issue 8, 1999, Pages 1321-1327

  Assaraf, Yehuda G ^b   Sierra, Esteban E ^a   Babani, Solomon ^a   Goldman, I David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

(anti)folate transport; Efflux transporters; Prostaglandin A1; Reduced folate carrier

Indexed keywords

ABC TRANSPORTER; FOLIC ACID; METHOTREXATE; PROSTAGLANDIN A1;

ACTIVE TRANSPORT; ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; EFFUSION; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; OVARY CANCER; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL MEMBRANE; CHO CELLS; CRICETINAE; FOLIC ACID; FOLIC ACID ANTAGONISTS; METHOTREXATE; PROSTAGLANDINS A; RECEPTORS, CELL SURFACE;

EID: 0032865435     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00227-0     Document Type: Article

References (37)

1. Blakely R.D., Benkovic S.J. Folates and Pterins Chemistry and Biochemistry of Pterins . 1985;John Wiley, New York.
2. Blakely R.D., Whitehead V.M. Folates and Pterins Nutritional, Pharmacological, and Physiological Aspects . 1986;John Wiley, New York.
3. Goldman I.D. The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann NY Acad Sci. 186:1971;400-422.
4. Henderson G.B., Zevely E.M. Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem Biophys Res Commun. 99:1981;163-169.
5. Sirotnak F.M. Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport Biological significance and implications for improved therapy of human cancer . Cancer Res. 45:1985;3992-4000.
6. Henderson G.B., Zevely E.M. Transport routes utilized by L1210 cells for the influx and efflux of methotrexate. J Biol Chem. 259:1984;1526-1531.
7. Saxena M., Henderson G.B. Identification of efflux systems for large anions and anionic conjugates as the mediators of methotrexate efflux in L1210 cells. Biochem Pharmacol. 51:1996;975-982.
8. Assaraf Y.G., Goldman I.D. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells. J Biol Chem. 272:1997;17460-17466.
9. Dembo M., Sirotnak F.M., Moccio D.M. Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells Further evidence for separate influx and efflux systems with different energetic requirements . J Membr Biol. 78:1984;9-17.
10. Goldman I.D. Transport energetics of the folic acid analogue, methotrexate, in L1210 cells Enhanced accumulation by metabolic inhibitors . J Biol Chem. 244:1969;3779-3785.
11. Fyfe M.J., Goldman I.D. Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells. J Biol Chem. 248:1973;5067-5073.
12. Henderson G.B., Montague-Wilkie B. Irreversible inhibitors of methotrexate transport in L1210 cells. Characteristics of inhibition by an N-hydroxysuccinimide ester of methotrexate. Biochim Biophys Acta. 735:1983;123-130.
13. Sirotnak F.M., Moccio D.M., Young C.W. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. Cancer Res. 41:1981;966-970.
14. Henderson G.B., Zevely E.M. Structural requirements for anion substrates of the methotrexate transport system of L1210 cells. Arch Biochem Biophys. 221:1983;438-446.
15. Gewirtz D.A., Plotkin J.H., Randolph J.K. Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension. Cancer Res. 44:1984;3846-3850.
16. Henderson G.B., Zevely E.M. Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells. Biochem Pharmacol. 34:1985;1725-1729.
17. Fry D.W., Besserer J.A., Boritzki T.J. Transport of the antitumor antibiotic CI-920 into L1210 leukemia cells by the reduced folate carrier system. Cancer Res. 44:1984;3366-3370.
18. Henderson G.B., Stein C.A. 5′-Cholesteryl-phosphorothioate oligodeoxynucleotides Potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier . Nucleic Acids Res. 23:1995;3726-3731.
19. Bito L.Z., Baroody R.A. Impermeability of rabbit erythrocytes to prostaglandins. Am J Physiol. 229:1975;1580-1584.
20. Fry D.W., Yalowich J.C., Goldman I.D. Rapid formation of poly-γ-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem. 257:1982;1890-1896.
21. Brigle K.E., Spinella M.J., Sierra E.E., Goldman I.D. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line. J Biol Chem. 270:1995;22974-22979.
22. Assaraf Y.G., Babani S., Goldman I.D. Increased activity of a novel low pH folate transporter associated with lipophilic antifolate resistance in Chinese hamster ovary cells. J Biol Chem. 273:1998;8106-8111.
23. Kanai N., Lu R., Satriano J.A., Bao Y., Wolkoff A.W., Schuster V.L. Identification and characterization of a prostaglandin transporter. Science. 268:1995;866-869.
24. 2. J Pharm Sci. 84:1995;523-529.
25. Henderson G.B., Tsuji J.M. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells. Biochim Biophys Acta. 1051:1990;60-70.
26. Henderson G.B., Hughes T.R., Saxena M. Functional implications from the effects of 1-chloro-2,4-dinitrobenzene and ethacrynic acid on efflux routes for methotrexate and cholate in L1210 cells. J Biol Chem. 269:1994;13382-13389.
27. Rindler M.J., Bashor M.M., Spitzer N., Saier M.H. Jr. Regulation of adenosine 3′, 5′-monophosphate efflux from animal cells. J Biol Chem. 253:1978;5431-5436.
28. Sirotnak F.M., Moccio D.M., Yang C. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. J Biol Chem. 259:1984;13139-13144.
29. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J.T., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547.
30. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
31. Paulusma C.C., Bosma P.J., Zaman G.J., Bakker C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., Oude Elferink R.P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 271:1996;1126-1128.
32. Paulusma C.C., Kool M., Bosma P.J., Scheffer G.L., Ter Borg F., Scheper R.J., Tytgat G.N.J., Borst P., Baas F., Elferink P.J.O. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. 25:1997;1539-1542.
33. Buchler M., Konig J., Brom M., Kartenbeck J., Spring H., Horie T., Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem. 271:1996;15091-15098.
34. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol. 272:(1 Pt 1):1997;G16-G22.
35. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S., Kuwano M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56:1996;4124-4129.
36. Masuda M., I'izuka Y., Yamazaki M., Nishigaki R., Kato Y., Ni'inuma K., Suzuki H., Sugiyama Y. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res. 57:1997;3506-3510.
37. Hooijberg J.H., Broxterman H.J., Kool M., Assaraf Y.G., Peters G.J., Noordhuis P., Scheper R.J., Borst P., Pinedo H.M., Jansen G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59:1999;2532-2535.